VitMode

Tool

Supplement comparison tool

Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.

Add to comparison (2/4)

 
CategoryLekiLeki
Evidence strengthModerate evidenceStrong evidence
Evidence Score3/55/5
User rating4.3 (58)4.5 (168)
Typical doseIn approved indications: usually 200 mg once daily in the morning (narcolepsy, sleep apnea) or about an hour before a night shift begins (shift-work disorder) — by prescription and under medical supervision onlyTopical form: 1 ml of 5% solution or the equivalent foam dose, applied twice daily to dry scalp (women sometimes use 5% foam once daily or a 2% solution). Oral form (LDOM, off-label): typically 0.625-5 mg/day, most often 1.25-2.5 mg, individually dosed by a physician
FormOral tabletsTopical solution or foam; tablets split for the oral form (compounding pharmacy preparation)
Average priceLek na receptę — cena i refundacja zależą od wskazania, zwykle 60–150 zł za opakowanie bez refundacji35-90 zł za opakowanie formy miejscowej starczające na miesiąc stosowania (cena zależy od koncentracji, formy i producenta — generyki są tańsze niż marki oryginalne)
Monthly costok. 60–150 zł/miesiąc przy codziennym stosowaniu bez refundacjiok. 35-90 zł/miesiąc dla formy miejscowej; forma doustna (receptura) zwykle wychodzi wyraźnie taniej, ale wymaga recepty i wizyty lekarskiej
Time to effectsThe wake-promoting effect usually appears within 1–2 hours of taking a dose and lasts most of the day due to its long half-life (about 12–15 hours).The temporary shedding phase can appear as early as weeks 2-8 of treatment. The first visible signs of regrowth usually appear after 3-4 months of consistent use, with a fully assessable clinical effect after 6-12 months of uninterrupted treatment. The effect requires indefinite continuation; it fades within a few months of stopping.
Who it's forPatients with a confirmed narcolepsy diagnosis, qualified by a neurologist or sleep medicine specialistMen with early- to moderate-stage androgenetic alopecia, especially in the crown area (less effective where follicles are already completely lost in advanced frontal balding)